InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
12
T+90 hit rate
33%
T+90 mean return
+0.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Dreyer Scott, Vice-Président Exécutif et Directeur Commercial. Officer active across 2 companies, notably COLLEGIUM PHARMACEUTICAL, INC. In total, 22 filings have been recorded. Split: 0 buy · 12 sells. Total volume traded: €3.1m. History available since 12 July 2021. The latest transaction was filed on 20 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations22 total
1,927 shares@ US$30.00051.2% of flowCommon StockSEC:0001062993-25-006148:0
15,387 shares@ US$30.00410.0% of flowCommon StockSEC:0001062993-25-005834:0
2,255 shares@ US$30.00491.5% of flowCommon StockSEC:0001062993-25-005752:0
15,387 shares@ US$30.00410.1% of flowCommon StockSEC:0001062993-25-005396:0
3,295 shares@ US$30.00112.2% of flowCommon StockSEC:0001062993-25-005020:0
45,016 shares0Common StockSEC:0001062993-25-002179:0
51,209 shares@ US$24.0326.8% of flowCommon StockSEC:0001062993-24-011338:0
9,336 shares@ US$36.37547.4% of flowCommon StockSEC:0001062993-24-004754:0
35,000 shares0Common StockSEC:0001062993-24-003169:0
23,560 shares@ US$32.280116.3% of flowCommon StockSEC:0001062993-24-001028:0
13,324 shares@ US$26.707.9% of flowCommon StockSEC:0001062993-23-005854:0
44,275 shares0Common StockSEC:0001062993-23-003474:0
10,424 shares@ US$27.086.2% of flowCommon StockSEC:0001062993-23-000826:0
594 shares@ US$17.480.2% of flowCommon StockSEC:0001062993-22-016312:0
10,559 shares@ US$21.610.014% mcap46.4% of flowCommon StockSEC:0001062993-22-005911:0
52,500 shares0Common StockSEC:0001062993-22-004318:0
701 shares@ US$19.050.3% of flowCommon StockSEC:0001879789-22-000002
701 shares@ US$19.050.0008% mcap2.7% of flowCommon StockSEC:0001879789-22-000002:0
5,693 shares@ US$18.332.2% of flowCommon StockSEC:0001879789-21-000022
5,693 shares@ US$18.330.0063% mcap21.4% of flowCommon StockSEC:0001879789-21-000022:0
595 shares@ US$23.170.3% of flowCommon StockSEC:0001104659-21-092117
595 shares@ US$23.170.0008% mcap2.7% of flowCommon StockSEC:0001104659-21-092117:0
22 of 22 declarations
About Dreyer Scott
Scott Dreyer is the EVP & Chief Commercial Officer at Collegium Pharmaceutical, Inc. He is responsible for the commercial strategy and business development of the company. His expertise is essential for Collegium's growth and innovation.
